MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

30 May 2022 Evaluate
A decrease of about -64.43% in the sales to Rs. 609.19 millions was observed for the quarter ended March 2022. The sales stood at Rs. 1712.87 millions during the similar quarter previous year.Net profit of the cmpany stood at Rs. 90.59 millions for the quarter ended March 2022 a decline of -59.22% from Rs. 222.13 millions  in the same quarter last year.Operating profit Margin for the quarter ended March 2022 slipped to -38.61% as compared to 423.97% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 609.19 1712.87 -64.43 5198.74 5631.78 -7.69 5198.74 5631.78 -7.69
Other Income 4.26 13.03 -67.31 51.98 34.53 50.54 51.98 34.53 50.54
PBIDT -38.61 423.97 -109.11 1196.83 1245.63 -3.92 1196.83 1245.63 -3.92
Interest 43.41 25.48 70.37 188.75 111.62 69.10 188.75 111.62 69.10
PBDT -82.02 398.49 -120.58 1008.08 1134.01 -11.10 1008.08 1134.01 -11.10
Depreciation 79.72 55.41 43.87 321.52 222.82 44.30 321.52 222.82 44.30
PBT -161.74 343.08 -147.14 686.56 911.19 -24.65 686.56 911.19 -24.65
TAX -252.33 120.95 -308.62 6.18 301.55 -97.95 6.18 301.55 -97.95
Deferred Tax -221.54 65.49 -438.28 -143.02 141.09 -201.37 -143.02 141.09 -201.37
PAT 90.59 222.13 -59.22 680.38 609.64 11.60 680.38 609.64 11.60
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) -6.34 24.75 -125.61 23.02 22.12 4.09 23.02 22.12 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..